Eli Lilly (LLY) Receives FDA Approval of Strattera for Treatment … - StreetInsider.com (subscription)
|
Eli Lilly (LLY) Receives FDA Approval of Strattera for Treatment …
StreetInsider.com (subscription), MI - May 8, 2008 Eli Lilly and Company (NYSE: LLY) announced that the United States Food and Drug Administration (FDA) has approved Strattera (atomoxetine HCI) for … |
Find Out More:
Books:
- Taking Charge of ADHD: The Complete, Authoritative Guide for Parents (Revised Edition)
- Concerta Side Effects
- ADHD: Attention-Deficit Hyperactivity Disorder in Children, Adolescents, and Adults
- Dyslexia Treatment
- Ritalin-Free Kids: Safe and Effective Homeopathic Medicine for ADHD and Other Behavioral and Learning Problems
May 11th, 2008
Strattera
Leave a Reply